The promise of epigenomic therapeutics in pancreatic cancer

The promise of epigenomic therapeutics in pancreatic cancer

Item
http://www.wikidata.org/entity/Q41473804
Autophagy Induced during Pancreatitis Promotes KRAS-Dependent Transformation in the PancreasAlterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical ImplicationsMiR-377 reverses cancerous phenotypes of pancreatic cells via suppressing DNMT1 and demethylating tumor suppressor genes.[Autophagy contributes to the initiation of pancreatic cancer].Epigenetic inhibition of miR-663b by long non-coding RNA HOTAIR promotes pancreatic cancer cell proliferation via up-regulation of insulin-like growth factor 2.Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners.Depletion of tumor-associated macrophages switches the epigenetic profile of pancreatic cancer infiltrating T cells and restores their anti-tumor phenotype.DNA-Methyltransferase 1 Induces Dedifferentiation of Pancreatic Cancer Cells through Silencing of Krüppel-Like Factor 4 Expression.Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes.
P2860

The promise of epigenomic therapeutics in pancreatic cancer

Item
http://www.wikidata.org/entity/Q41473804
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The promise of epigenomic therapeutics in pancreatic cancer
@en
type
label
The promise of epigenomic therapeutics in pancreatic cancer
@en
prefLabel
The promise of epigenomic therapeutics in pancreatic cancer
@en
P1433
P1476
P2093
P275
P2860
P304
P31
P356
P433
P478
P5008
P577
P698
P921
P932
P356
P1433
P1476
The promise of epigenomic therapeutics in pancreatic cancer
@en
P2093
P275
P2860
P304
P31
P356
P433
P478
P5008
P577
P698
P921
P932